Skip to main content
FinSpry Logo
FinSpry
NKTR logo
NKTR
(NASDAQ)
Nektar Therapeutics
$76.99-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Nektar Therapeutics (NKTR) Stock Price & Financial Analysis

Nektar Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$73.04 - $78.00
52-Week High$78.81
52-Week Low$6.48
Open$73.55
Volume552.66K
Average Volume (3M)552.66K
Market Cap1.46B
Shares Outstanding18.95M
Price to Sales (P/S)22.91
Price to Book (P/B)16.86
EV/EBITDA-17.26
Revenue (TTM)62.60M
Net Income (TTM)-120.74M
Free Cash Flow (TTM)-190.35M
EPS (TTM)$-6.37
Profit Margin-192.87%
Operating Margin-217.83%
Return on Equity (ROE)-141.90%
Debt to Equity1.08
50-Day MA$61.45
200-Day MA$47.14
52-Week Change692.03%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Nektar Therapeutics

What is the current stock price for NKTR?

As of the latest trading session, NKTR stock trades at $76.99. The 52-week range is $6.48–$78.81, with a day range of $73.04–$78.00.

What is the P/E ratio for NKTR?

The P/E ratio (Price-to-Earnings) for NKTR is shown in the Key Statistics section. This valuation metric helps compare Nektar Therapeutics to industry peers.

Does NKTR pay dividends?

Nektar Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NKTR?

Based on 6 analysts, the consensus for NKTR is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NKTR?

Nektar Therapeutics's market capitalization is $1.46B, classifying it as a small-cap company. Nektar Therapeutics operates in the Healthcare sector within the Biotechnology industry.